HOME >> BIOLOGY >> NEWS
UT Southwestern Researchers Find Way To Control Gene Activity, Opening Way For Cancer Drugs

DALLAS - May 12, 1999 - Researchers at UT Southwestern Medical Center at Dallas have developed a method to turn off a gene for telomerase, which activates the continuous division of cancer cells. This finding could aid in the creation of new cancer drugs.

The research team invented a novel method for slipping a small molecule, known as peptide nucleic acid (PNA), into cells, where it then blocked telomerase activity. Telomerase is an enzyme that prevents depletion of the ends -- telomeres -- of chromosomes and allows continuous cell division. The study was reported in the June issue of Chemistry and Biology published today.

Telomeres shorten each time the cell divides, 50 to 70 times during the lifetime of a normal cell. Once the protective tips of DNA are gone, the cells die. All human cells have a gene for telomerase, but it is switched off in normal cells, except embryonic cells, so the enzyme is not manufactured. It is switched on in tumor cells allowing them to divide uncontrollably and be immortal.

The same investigators published a related paper describing the rules for attacking DNA targets with PNAs. That study appeared in March in the Journal of the American Chemical Society.

"A challenge that researchers have faced in trying to switch genes on and off with any efficiency is to identify a small molecule that can enter cells, bind to a target gene and turn the gene off," said Dr. David Corey, co-author of the study, associate professor of pharmacology and biochemistry and a Howard Hughes Medical Institute (HHMI) investigator. "We have a simple way to get PNAs into cells, and we have determined rules guiding their ability to block DNA and RNA targets."

The scientists introduced PNAs into cells by adding a lipid -- a fat-soluble substance. This method allowed delivery of PNAs into the nucleus in almost 100 percent of the tests on two different cell lines, Corey said.

One of the most significant aspects of the work, especially in r
'"/>

Contact: Susan Steeves
susan.steeves@email.swmed.edu
214-648-3404
UT Southwestern Medical Center
12-May-1999


Page: 1 2

Related biology news :

1. UT Southwestern receives $1.78 million grant for obesity research as part of NIH Roadmap initiative
2. UT Southwestern biochemist honored with NIH Directors Pioneer Award
3. RSV can increase the risk of asthma, UT Southwestern researchers find
4. Searle Scholars program awards $240,000 to UT Southwestern researcher
5. Two molecules work together to aid transport of immune cells, UT Southwestern researchers find
6. Biochemist becomes 15th UT Southwestern faculty member serving on National Academy of Sciences
7. UT Southwestern researchers reveal mechanisms of smooth-muscle contraction
8. Fetal lungs provide a signal initiating labor, UT Southwestern researchers find
9. UT Southwestern researchers cite recent advances in underlying causes of rare body-fat disorders
10. UT Southwestern researchers discover link that could aid in treatment of kidney cyst diseases
11. UT Southwestern research halts narcolepsy symptoms

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2020)... MANSFIELD, Mass. (PRWEB) , ... June 24, 2020 ... ... provider of cloud-based enterprise software and software-driven clinical data services that accelerate drug ... trials for low-dose selinexor, an XPO1 inhibitor, in hospitalized patients with severe COVID-19. ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... and Renovagen Ltd, a UK supplier and manufacturer of innovative portable renewable energy ... operations in the fight against the COVID-19 pandemic in Zambia. , One of ...
(Date:6/23/2020)... ... June 23, 2020 , ... Rigaku Corporation ... next event in a series of TOPIQ webinars, which will cover the Transferable ... was developed in response to social distancing measures that resulted in postponements and ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... ... 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology company ... Nissenson, M.D., F.A.C.P., as its Chief Medical Officer. Dr. Nissenson will join ... Dr. Nissenson serves as an Emeritus Professor of Medicine at the David ...
(Date:7/1/2020)... N.C. (PRWEB) , ... June 29, 2020 , ... ... reported year to date growth of 40% in 2020, despite many obstacles created ... technology, MedShift aims to increase revenue for its partnered medical practices and medical ...
(Date:6/28/2020)... ... June 25, 2020 , ... The Indoor Lab, a ... Safe Space™ for businesses of all types to ensure cleanliness, distancing and occupancy with ... , A Safe Space™ enabled business will provide a health performance index system that ...
(Date:6/28/2020)... ... June 26, 2020 , ... The ... today announced its strong opposition to the recently introduced bicameral Facial Recognition ... ban on most federal use of nearly all biometric and related image analytics ...
Breaking Biology Technology:
Cached News: